Q2 2020

Filed Aug 12, 2020 · 10-Q · 43 days after period end · 0001683168-20-002645

Q2 2020 · 10-Q

Revenue

$112.93K

— vs Q2 2019

Net Income

-$953.64K

N/M vs Q2 2019

EPS Diluted

-$0.15

N/M vs Q2 2019

Operating Income-$982,459N/M

Operating Cash Flow

Same quarter

Metric	Q2 2020	Q2 2019	Q2 2018	Q2 2017
Revenue	$112.93K	$0.00	—	—
Net Income	-$953.64K	-$1.38M	-$2.03M	-$2.92M
EPS Diluted	-$0.15	-$1.56	-$2.78	-$0.34

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR